10. Cochlear
R&D spend: $143.0 million
Percent of revenues: 12.6%
2017 overall revenue rank: 58
The most significant technology to come out of Cochlear’s R&D in recent years is the new Cochlear Nucleus 7 sound processor. The Australia-based company touts the Nucleus 7 as the world’s first made-for-iPhone cochlear implant sound processor. Users can stream sound directly from a compatible iPhone, iPad and iPod touch directly to their sound processor, according to Cochlear (ASX: COH)